R D CLINICAL LIMITED

R D CLINICAL LIMITED

R D CLINICAL LIMITED - Company Information

Print Friendly Version

R D CLINICAL LIMITED

Company Registration Number:
NI602425 (Northern Ireland)

Unaudited abridged accounts for the year ended 31 March 2020

Period of accounts

Start date: 01 April 2019

End date: 31 March 2020

R D CLINICAL LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2020

Balance sheet
Notes

R D CLINICAL LIMITED

Balance sheet

As at 31 March 2020


Notes
2020
2019


£
£
Fixed assets
Intangible assets:   0 0
Tangible assets: 3 800 0
Investments: 4 194,225 192,225
Total fixed assets: 195,025 192,225
Current assets
Stocks: 0 0
Debtors:   0 0
Cash at bank and in hand: 267,669 178,477
Investments:   0 0
Total current assets: 267,669 178,477
Creditors: amounts falling due within one year: 5 (23,032) (20,444)
Net current assets (liabilities): 244,637 158,033
Total assets less current liabilities: 439,662 350,258
Creditors: amounts falling due after more than one year:   0 0
Provision for liabilities: 0 0
Total net assets (liabilities): 439,662 350,258
Capital and reserves
Called up share capital: 100 100
Share premium account: 0 0
Revaluation reserve: 00
Other reserves: 0 0
Profit and loss account: 439,562 350,158
Shareholders funds: 439,662 350,258

The notes form part of these financial statements

R D CLINICAL LIMITED

Balance sheet statements

For the year ending 31 March 2020 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 20 January 2021
and signed on behalf of the board by:

Name: Robin Davidson
Status: Director

The notes form part of these financial statements

R D CLINICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2020

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

R D CLINICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2020

2. Employees

2020 2019
Average number of employees during the period 2 2

R D CLINICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2020

3. Tangible Assets

Total
Cost £
At 01 April 2019 2,290
Additions 800
Disposals 0
Revaluations 0
Transfers 0
At 31 March 2020 3,090
Depreciation
At 01 April 2019 2,290
Charge for year 0
On disposals 0
Other adjustments 0
At 31 March 2020 2,290
Net book value
At 31 March 2020 800
At 31 March 2019 0

R D CLINICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2020

4. Fixed investments

Freehold Property Cost £194,225

R D CLINICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2020

5. Creditors: amounts falling due within one year note

Creditors due within one year £23,032